Dr. David Michael Pilkington is a dermatologist in Merced,California. He graduated from University of California, San Francisco School of Medicine in 1991 and has been in practice for 31 years.
University of California, San Francisco School of Medicine, 1991
Male
1295751931
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Tangential biopsy of single skin lesion | 474.0 | 434.0 | 209.68744726 |
| Tangential biopsy of additional skin lesion | 180.0 | 124.0 | 111.84438889 |
| Punch biopsy of single skin lesion | 37.0 | 37.0 | 265.2 |
| Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 20.0 | 20.0 | 358.875 |
| Removal of growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | 13.0 | 12.0 | 414.12 |
| Removal of growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals | 19.0 | 18.0 | 388.72736842 |
| Removal of growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth | 13.0 | 12.0 | 410.38153846 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 142.0 | 111.0 | 530.07169014 |
| Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | 40.0 | 32.0 | 609.62125 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals | 77.0 | 72.0 | 544.64844156 |
| Removal of malignant growth (2.1 to 3.0 centimeters) of the scalp, neck, hands, feet, or genitals | 14.0 | 12.0 | 638.99214286 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips | 167.0 | 136.0 | 570.61676647 |
| Removal of malignant growth (2.1 to 3.0 centimeters) of the face, ears, eyelids, nose, or lips | 13.0 | 13.0 | 670.8 |
| Injection of up to 7 skin growths | 48.0 | 41.0 | 111.745 |
| Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | 217.0 | 174.0 | 653.49410138 |
| Repair of wound (7.6 to 12.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | 13.0 | 11.0 | 681.98461538 |
| Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals | 68.0 | 68.0 | 632.87941176 |
| Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | 164.0 | 139.0 | 632.16768293 |
| Destruction of skin growth | 2520.0 | 1691.0 | 138.11403175 |
| Destruction of 2-14 skin growths | 9988.0 | 1297.0 | 11.911401682 |
| Destruction of 15 or more skin growths | 1218.0 | 743.0 | 320.20097701 |
| Destruction of up to 14 skin growths | 1562.0 | 1199.0 | 235.49427657 |
| Biopsy of soft tissue of neck or chest | 15.0 | 14.0 | 570.69333333 |
| Biopsy of tissue of back or flank | 11.0 | 11.0 | 545.09 |
| Biopsy of ear | 47.0 | 39.0 | 211.06340426 |
| Pathology examination of tissue using a microscope, intermediate complexity | 1366.0 | 729.0 | 86.457335286 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 71.0 | 44.0 | 35.89028169 |
| Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session | 49.0 | 28.0 | 384.9877551 |
| Skin application of tar and ultraviolet B or petrolatum and ultraviolet B | 482.0 | 15.0 | 240.29655602 |
| New patient office or other outpatient visit, typically 20 minutes | 447.0 | 447.0 | 159.11691275 |
| New patient office or other outpatient visit, typically 30 minutes | 50.0 | 50.0 | 225.41 |
| Established patient office or other outpatient visit, typically 10 minutes | 749.0 | 569.0 | 98.375220294 |
| Established patient office or other outpatient visit, typically 15 minutes | 3703.0 | 2140.0 | 154.63267891 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 403.0 | 75.0 | 11.808883375 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 29.0 | 17.0 | 512.81586207 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 3400.0 | 14.0 | 12.13 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.